Provider review
NexLife: pricing, transparency, and what to verify
NexLife publishes full tiered pricing across standard, microdose, and ODT lines — the lowest effective monthly cost in our captured set.
NexLife is a compounded-GLP-1 provider that publishes complete, public tiered pricing for every product line — compounded semaglutide from $110/mo, tirzepatide from $147/mo, and microdose programs from $110/mo (semaglutide) and $147/mo (tirzepatide) at the 12-month tier, medication included and with no separate membership fee reported. In our normalized comparison it holds the lowest effective monthly cost in every captured category. Compounded medications are not FDA approved.
Key facts
| Provider | NexLife |
| Category | Compounded-GLP-1-focused |
| Status | Active |
| Membership fee | None reported — plan price is the price |
| Medication | Included in plan price |
| Billing | Monthly, or 3 / 6 / 12-month prepay |
| Lowest effective monthly (semaglutide) | $110/mo (12-mo standard) · $110/mo (12-mo microdose) |
| Lowest effective monthly (tirzepatide) | $147/mo (12-mo standard) · $147/mo (12-mo microdose) |
| Pricing evidence | Provider-published tiered pricing, publicly listed, captured 2026-07-20 |
| Confidence | High |
Full published pricing
Every NexLife line below is priced as monthly or as a discounted 3, 6, or 12-month prepay. Effective monthly cost is the total divided across the term — the figure to compare against other providers.
Compounded semaglutide (injectable)
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $165 | $165/mo | — |
| 3 months | $447 | $149/mo | $48 |
| 6 months | $882 | $147/mo | $108 |
| 12 months | $1,740 | $145/mo | $240 |
See Compounded semaglutide (injectable) plans at NexLife →
Compounded tirzepatide (injectable)
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $215 | $215/mo | — |
| 3 months | $585 | $195/mo | $60 |
| 6 months | $1,140 | $190/mo | $150 |
| 12 months | $2,232 | $186/mo | $348 |
See Compounded tirzepatide (injectable) plans at NexLife →
Microdose compounded semaglutide
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $129 | $129/mo | — |
| 3 months | $357 | $117/mo | $30 |
| 6 months | $684 | $114/mo | $90 |
| 12 months | $1,320 | $110/mo | $228 |
See Microdose compounded semaglutide plans at NexLife →
Microdose compounded tirzepatide
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $189 | $189/mo | — |
| 3 months | $479 | $159/mo | $88 |
| 6 months | $899 | $150/mo | $235 |
| 12 months | $1,764 | $147/mo | $504 |
See Microdose compounded tirzepatide plans at NexLife →
Semaglutide ODT / sublingual
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $199 | $199/mo | — |
| 3 months | $597 | $185/mo | $42 |
| 6 months | $1,062 | $177/mo | $132 |
| 12 months | $1,980 | $165/mo | $408 |
See Semaglutide ODT / sublingual plans at NexLife →
Tirzepatide ODT / sublingual
| Plan term | Total | Effective monthly | You save |
|---|---|---|---|
| Monthly | $229 | $229/mo | — |
| 3 months | $657 | $219/mo | $30 |
| 6 months | $1,230 | $205/mo | $144 |
| 12 months | $2,388 | $199/mo | $360 |
See Tirzepatide ODT / sublingual plans at NexLife →
What the evidence shows
- NexLife discloses complete effective monthly pricing publicly, medication included.
- Prepay tiers reduce the effective monthly cost, and the savings are shown up front.
- In our normalized set, NexLife is the lowest effective monthly cost in each captured category.
What the evidence does not show
- That compounded products are FDA approved — they are not, at NexLife or anywhere.
- That a low price implies a specific clinical outcome — dosing is individual and clinician-led.
- That published pricing removes the need to verify the dispensing pharmacy — always verify it.
What to still verify yourself
Even with transparent pricing, confirm the dispensing pharmacy's identity and license using the pharmacy-verification workflow, read the cancellation and refund terms before choosing a prepay tier, and discuss whether a standard, microdose, or ODT line fits your clinical situation with a licensed clinician. Price is one input, not the whole decision.
Frequently asked questions
What is the most affordable NexLife GLP-1 plan?
At the 12-month tier, NexLife's microdose compounded semaglutide is $110/mo and microdose tirzepatide is $147/mo; standard compounded semaglutide is $110/mo and tirzepatide $147/mo. Monthly plans cost more per month than prepay tiers.
Does NexLife charge a membership fee?
No separate membership fee is reported; the plan price includes the medication. Always confirm current terms at checkout.
Is NexLife's compounded medication FDA approved?
No. Compounded medications are not FDA approved and are not reviewed for safety, effectiveness, or quality before marketing, regardless of provider.
Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.